Not yet recruitingNot applicableNCT07073729

Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study

Studying Neurotrophic keratopathy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Principal Investigator: Alex Camacho, MD, MSc
Western University, Ophthalmology
Intervention: Corneal Neurotization(procedure)
Enrollment: 10 target
Eligibility: 19 years · All sexes
Timeline: 2025 – 2027

Study locations (1)

Ivey Eye Institute, St. Joseph's Health Care London, London, Ontario, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07073729 on ClinicalTrials.gov

Other trials for Neurotrophic keratopathy

Additional recruiting or active studies for the same condition.

See all trials for Neurotrophic keratopathy →

← Back to all trials